Investment Woes Amidst Pharmaceutical Tensions in Britain
Published on: Sept. 11, 2025, 11:31 p.m. | Source: Devdiscourse
Britain's pharmaceutical industry faces challenges as U.S. drugmaker Merck halts its UK research center plans. The life sciences sector is under strain with the exit of major projects amid difficult business conditions exacerbated by U.S. tariff pressures and industry-government pricing disputes.
